Ireland
--:--IST
Enrolling by invitation Observational

Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

NCT06903247 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-03-15
Last updated
2025-11-18

Condition(s) studied

Neurosonographic Findings of Vitamin D Deficiency

Investigational drug(s) / intervention(s)

Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.

Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.: Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency.

Study summary

In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria:Patients presenting for routine antenatal care between 20-30 weeks of gestation will be included. Exclusion Criteria:Multiple pregnancy, preterm rupture of membranes, chorioamnionitis, placental abruption, severe fetal growth restriction, congenital fetal anomalies, preeclampsia, oligohydramnios and maternal diabetes.

Primary outcome measure(s)

  • Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation. — Neurosonogram Results Performed Between 20-30 Weeks of Gestation.

Trial sites (1)

FacilityCityRegionStatus
Sanliurfa Education and Research Hospital Sanliurfa Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06903247 on ClinicalTrials.gov ↗ ← All trials in Turkey